Moberg Pharma AB   Report issue

For profit Phase 2 Phase 3
Founded: Bromma Sweden (2006)

Organization Overview

First Clinical Trial
2007
NCT01137630
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Moberg Pharma AB | MOBERG PHARMA NORTH | Moberg Pharma, Sweden